Assertio (NASDAQ:ASRT - Get Free Report) was upgraded by research analysts at StockNews.com from a "hold" rating to a "buy" rating in a research note issued on Tuesday.
Assertio Stock Down 9.0 %
Shares of Assertio stock traded down $0.11 on Tuesday, hitting $1.11. The company had a trading volume of 1,343,982 shares, compared to its average volume of 1,044,132. Assertio has a twelve month low of $0.73 and a twelve month high of $8.01. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.83 and a quick ratio of 1.43. The stock has a 50-day moving average of $0.94 and a 200-day moving average of $1.08. The firm has a market capitalization of $105.58 million, a P/E ratio of -0.28 and a beta of 1.00.
Assertio (NASDAQ:ASRT - Get Free Report) last released its earnings results on Monday, March 11th. The company reported $0.08 earnings per share (EPS) for the quarter. Assertio had a positive return on equity of 6.30% and a negative net margin of 218.28%. The firm had revenue of $32.99 million during the quarter, compared to analysts' expectations of $31.42 million. Research analysts predict that Assertio will post -0.04 earnings per share for the current year.
Institutional Investors Weigh In On Assertio
Several institutional investors have recently bought and sold shares of ASRT. Principal Financial Group Inc. acquired a new stake in shares of Assertio in the third quarter valued at approximately $32,000. Strs Ohio acquired a new stake in Assertio in the 3rd quarter valued at $33,000. Barclays PLC lifted its position in Assertio by 32.1% during the 3rd quarter. Barclays PLC now owns 22,990 shares of the company's stock worth $59,000 after buying an additional 5,588 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Assertio by 45.4% during the 4th quarter. SG Americas Securities LLC now owns 55,769 shares of the company's stock worth $60,000 after buying an additional 17,417 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System grew its holdings in shares of Assertio by 61.9% in the 3rd quarter. State Board of Administration of Florida Retirement System now owns 25,370 shares of the company's stock valued at $65,000 after acquiring an additional 9,700 shares in the last quarter. Institutional investors own 48.96% of the company's stock.
About Assertio
(
Get Free Report)
Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Assertio, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assertio wasn't on the list.
While Assertio currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
